Скачать или смотреть Podcast — Cannabis and Clinical Trials Overview with Dr. Beatrice Setnik and Ingrid Holmes

In this podcast, Altasciencse' Dr. Beatrice Setnik, PhD, Chief Scientific Officer, and Ingrid Holmes, Vice President of Clinical Operations, provide a general overview of clinical trial methods, study designs, and regulatory considerations for your cannabis clinical trials.

From conducting the world's first safety and tolerability testing of a novel combustible cannabis formulation, to testing synthetic cannabinoids or products for the recreational market, Altasciences' clinical trial experts are world leaders in cannabis testing. We have over 10 years of experience in cannabis studies, conducting nearly 40 studies on different cannabis products, cannabinoids, or with cannabis users.

We have extensive experience with all routes of administration:
Combustible
Vaping
Tablets
Oils
Sublingual
Topical gels

We have worked with whole plant extracts and isolated phytocannabinoids or fully synthetic cannabinoids. Our bioanalytical laboratory has validated methods for THC, CBD, and three other cannabinoids.

We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

Visit our website to learn more about our clinical solutions: https://www.altasciences.com/clinical...